AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
IS AXILLARY LYMPH-NODE DISSECTION INDICATED FOR EARLY-STAGE BREAST-CANCER - A DECISION-ANALYSIS
Authors: PROSNITZ LR PARMIGIANI G WINER EP TEBALDI C IGLEHART JD BERRY DA
Citation: Lr. Prosnitz et al., IS AXILLARY LYMPH-NODE DISSECTION INDICATED FOR EARLY-STAGE BREAST-CANCER - A DECISION-ANALYSIS, European journal of cancer, 34, 1998, pp. 53-53
COMPLEX RESPONSE OF BREAST EPITHELIAL-CELL LINES TO TOPOISOMERASE INHIBITORS
Authors: DAVIS PL SHAIU WL SCOTT GL IGLEHART JD HSIEH TS MARKS JR
Citation: Pl. Davis et al., COMPLEX RESPONSE OF BREAST EPITHELIAL-CELL LINES TO TOPOISOMERASE INHIBITORS, Anticancer research, 18(4C), 1998, pp. 2919-2932
PREDICTING RESPONSE TO ADJUVANT AND RADIATION-THERAPY IN PATIENTS WITH EARLY-STAGE BREAST-CARCINOMA
Authors: BURKE HB HOANG A IGLEHART JD MARKS JR
Citation: Hb. Burke et al., PREDICTING RESPONSE TO ADJUVANT AND RADIATION-THERAPY IN PATIENTS WITH EARLY-STAGE BREAST-CARCINOMA, Cancer, 82(5), 1998, pp. 874-877
EXPRESSION OF TIE2 TEK IN BREAST-TUMOR VASCULATURE PROVIDES A NEW MARKER FOR EVALUATION OF TUMOR ANGIOGENESIS/
Authors: PETERS KG COOGAN A BERRY D MARKS J IGLEHART JD KONTOS CD RAO P SANKAR S TROGAN E
Citation: Kg. Peters et al., EXPRESSION OF TIE2 TEK IN BREAST-TUMOR VASCULATURE PROVIDES A NEW MARKER FOR EVALUATION OF TUMOR ANGIOGENESIS/, British Journal of Cancer, 77(1), 1998, pp. 51-56
OVERESTIMATION OF HEREDITARY BREAST-CANCER RISK
Authors: IGLEHART JD MIRON A RIMER BK WINER EP BERRY D SHILDKRAUT JM
Citation: Jd. Iglehart et al., OVERESTIMATION OF HEREDITARY BREAST-CANCER RISK, Annals of surgery, 228(3), 1998, pp. 375-383
OVERESTIMATION OF HEREDITARY BREAST-CANCER RISK - DISCUSSION
Authors: WELLS SA IGLEHART JD WOOD WC ORGAN CH SCHWARTZ SI
Citation: Sa. Wells et al., OVERESTIMATION OF HEREDITARY BREAST-CANCER RISK - DISCUSSION, Annals of surgery, 228(3), 1998, pp. 383-384
TRANSFECTION OF THE TYPE-II TGF-BETA RECEPTOR INTO COLON-CANCER CELLSINCREASES RECEPTOR EXPRESSION, INHIBITS CELL-GROWTH, AND REDUCES THE MALIGNANT PHENOTYPE - DISCUSSION
Authors: IGLEHART JD EVERS BM NORMAN J MACKAY SLD
Citation: Jd. Iglehart et al., TRANSFECTION OF THE TYPE-II TGF-BETA RECEPTOR INTO COLON-CANCER CELLSINCREASES RECEPTOR EXPRESSION, INHIBITS CELL-GROWTH, AND REDUCES THE MALIGNANT PHENOTYPE - DISCUSSION, Annals of surgery, 227(6), 1998, pp. 788-789
USE OF PARAVERTEBRAL BLOCK ANESTHESIA IN THE SURGICAL-MANAGEMENT OF BREAST-CANCER - EXPERIENCE IN 156 CASES
Authors: COVENEY E WELTZ CR GREENGRASS R IGLEHART JD LEIGHT GS STEELE SM LYERLY HK
Citation: E. Coveney et al., USE OF PARAVERTEBRAL BLOCK ANESTHESIA IN THE SURGICAL-MANAGEMENT OF BREAST-CANCER - EXPERIENCE IN 156 CASES, Annals of surgery, 227(4), 1998, pp. 496-501
BRCA1 EXPRESSION IS NOT DIRECTLY RESPONSIVE TO ESTROGEN
Authors: MARKS JR HUPER G VAUGHN JP DAVIS PL NORRIS J MCDONNELL DP WISEMAN RW FUTREAL PA IGLEHART JD
Citation: Jr. Marks et al., BRCA1 EXPRESSION IS NOT DIRECTLY RESPONSIVE TO ESTROGEN, Oncogene, 14(1), 1997, pp. 115-121
PREDICTING BREAST-CANCER INVASION WITH ARTIFICIAL NEURAL NETWORKS ON THE BASIS OF MAMMOGRAPHIC FEATURES
Authors: LO JY BAKER JA KORNGUTH PJ IGLEHART JD FLOYD CE
Citation: Jy. Lo et al., PREDICTING BREAST-CANCER INVASION WITH ARTIFICIAL NEURAL NETWORKS ON THE BASIS OF MAMMOGRAPHIC FEATURES, Radiology, 203(1), 1997, pp. 159-163
FINE-NEEDLE ASPIRATION OF LOW-GRADE ADENOSQUAMOUS CARCINOMA OF THE BREAST
Authors: KRIGMAN HR IGLEHART JD COOGAN AC LAYFIELD LJ
Citation: Hr. Krigman et al., FINE-NEEDLE ASPIRATION OF LOW-GRADE ADENOSQUAMOUS CARCINOMA OF THE BREAST, Diagnostic cytopathology, 14(4), 1996, pp. 321-324
RELATIONSHIP BETWEEN P21 EXPRESSION AND MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IN NORMAL AND MALIGNANT OVARIAN EPITHELIAL-CELLS
Authors: ELBENDARY AA CIRISANO FD EVANS AC DAVIS PL IGLEHART JD MARKS JR BERCHUCK A
Citation: Aa. Elbendary et al., RELATIONSHIP BETWEEN P21 EXPRESSION AND MUTATION OF THE P53 TUMOR-SUPPRESSOR GENE IN NORMAL AND MALIGNANT OVARIAN EPITHELIAL-CELLS, Clinical cancer research, 2(9), 1996, pp. 1571-1575
BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS
Authors: LANCASTER JM WOOSTER R MANGION J PHELAN CM COCHRAN C GUMBS C SEAL S BARFOOT R COLLINS N BIGNELL G PATEL S HAMOUDI R LARSSON C WISEMAN RW BERCHUCK A IGLEHART JD MARKS JR ASHWORTH A STRATTON MR FUTREAL PA
Citation: Jm. Lancaster et al., BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS, Nature genetics, 13(2), 1996, pp. 238-240
BRCA1 EXPRESSION IS INDUCED BEFORE DNA-SYNTHESIS IN BOTH NORMAL AND TUMOR-DERIVED BREAST CELLS
Authors: VAUGHN JP DAVIS PL JARBOE MD HUPER G EVANS AC WISEMAN RW BERCHUCK A IGLEHART JD FUTREAL PA MARKS JR
Citation: Jp. Vaughn et al., BRCA1 EXPRESSION IS INDUCED BEFORE DNA-SYNTHESIS IN BOTH NORMAL AND TUMOR-DERIVED BREAST CELLS, Cell growth & differentiation, 7(6), 1996, pp. 711-715
DOMINANCE OF WILD-TYPE P53-MEDIATED TRANSCRIPTIONAL ACTIVATION IN BREAST EPITHELIAL-CELLS
Authors: DAVIS P BAZAR K HUPER G LOZANO G MARKS J IGLEHART JD
Citation: P. Davis et al., DOMINANCE OF WILD-TYPE P53-MEDIATED TRANSCRIPTIONAL ACTIVATION IN BREAST EPITHELIAL-CELLS, Oncogene, 13(6), 1996, pp. 1315-1322
M6P IGF2 RECEPTOR - A CANDIDATE BREAST-TUMOR SUPPRESSOR GENE/
Authors: HANKINS GR DESOUZA AT BENTLEY RC PATEL MR MARKS JR IGLEHART JD JIRTLE RL
Citation: Gr. Hankins et al., M6P IGF2 RECEPTOR - A CANDIDATE BREAST-TUMOR SUPPRESSOR GENE/, Oncogene, 12(9), 1996, pp. 2003-2009
INHIBITION OF THE ERB-2 TYROSINE KINASE RECEPTOR IN BREAST-CANCER CELLS BY PHOSPHOROMONOTHIOATE AND PHOSPHORODITHIOATE ANTISENSE OLIGONUCLEOTIDES
Authors: VAUGHN JP STEKLER J DEMIRDJI S MILLS JK CARUTHERS MH IGLEHART JD MARKS JR
Citation: Jp. Vaughn et al., INHIBITION OF THE ERB-2 TYROSINE KINASE RECEPTOR IN BREAST-CANCER CELLS BY PHOSPHOROMONOTHIOATE AND PHOSPHORODITHIOATE ANTISENSE OLIGONUCLEOTIDES, Nucleic acids research, 24(22), 1996, pp. 4558-4564
TISSUE TRANSGLUTAMINASE EXPRESSION IN HUMAN BREAST-CANCER
Authors: HETTASCH JM BANDARENKO N BURCHETTE JL LAI TS MARKS JR HAROON ZA PETERS K DEWHIRST MW IGLEHART JD GREENBERG CS
Citation: Jm. Hettasch et al., TISSUE TRANSGLUTAMINASE EXPRESSION IN HUMAN BREAST-CANCER, Laboratory investigation, 75(5), 1996, pp. 637-645
CELL-CYCLE CONTROL OF BRCA2
Authors: VAUGHN JP CIRISANO FD HUPER G BERCHUCK A FUTREAL PA MARKS JR IGLEHART JD
Citation: Jp. Vaughn et al., CELL-CYCLE CONTROL OF BRCA2, Cancer research, 56(20), 1996, pp. 4590-4594
QUANTITATIVE-ANALYSIS OF THE TRANSCRIPTIONAL START SITES OF ESTROGEN-RECEPTOR IN BREAST-CARCINOMA
Authors: WEIGEL RJ CROOKS DL IGLEHART JD DECONINCK EC
Citation: Rj. Weigel et al., QUANTITATIVE-ANALYSIS OF THE TRANSCRIPTIONAL START SITES OF ESTROGEN-RECEPTOR IN BREAST-CARCINOMA, Cell growth & differentiation, 6(6), 1995, pp. 707-711
MAINTENANCE OF DNA CONTENT AND ERBB-2 ALTERATIONS IN INTRADUCTAL AND INVASIVE PHASES OF MAMMARY-CANCER
Authors: IGLEHART JD KERNS BJ HUPER G MARKS JR
Citation: Jd. Iglehart et al., MAINTENANCE OF DNA CONTENT AND ERBB-2 ALTERATIONS IN INTRADUCTAL AND INVASIVE PHASES OF MAMMARY-CANCER, Breast cancer research and treatment, 34(3), 1995, pp. 253-263
ANTISENSE DNA DOWN-REGULATION OF THE ERBB2 ONCOGENE MEASURED BY A FLOW CYTOMETRIC ASSAY
Authors: VAUGHN JP IGLEHART JD DEMIRDJI S DAVIS P BABISS LE CARUTHERS MH MARKS JR
Citation: Jp. Vaughn et al., ANTISENSE DNA DOWN-REGULATION OF THE ERBB2 ONCOGENE MEASURED BY A FLOW CYTOMETRIC ASSAY, Proceedings of the National Academy of Sciences of the United Statesof America, 92(18), 1995, pp. 8338-8342
IDENTIFICATION OF A NEW SUBCLASS OF ALU DNA REPEATS WHICH CAN FUNCTION AS ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTIONAL ENHANCERS
Authors: NORRIS J FAN DJ ALEMAN C MARKS JR FUTREAL PA WISEMAN RW IGLEHART JD DEININGER PL MCDONNELL DP
Citation: J. Norris et al., IDENTIFICATION OF A NEW SUBCLASS OF ALU DNA REPEATS WHICH CAN FUNCTION AS ESTROGEN RECEPTOR-DEPENDENT TRANSCRIPTIONAL ENHANCERS, The Journal of biological chemistry, 270(39), 1995, pp. 22777-22782
PROGNOSTIC MODEL OF RECURRENCE AND DEATH IN STAGE-I NONSMALL CELL LUNG-CANCER UTILIZING PRESENTATION, HISTOPATHOLOGY, AND ONCOPROTEIN EXPRESSION
Authors: HARPOLE DH HERNDON JE WOLFE WG IGLEHART JD MARKS JR
Citation: Dh. Harpole et al., PROGNOSTIC MODEL OF RECURRENCE AND DEATH IN STAGE-I NONSMALL CELL LUNG-CANCER UTILIZING PRESENTATION, HISTOPATHOLOGY, AND ONCOPROTEIN EXPRESSION, Cancer research, 55(1), 1995, pp. 51-56
ELEVATED PLASMA TRANSFORMING GROWTH FACTOR-BETA(1) LEVELS IN BREAST-CANCER PATIENTS DECREASE AFTER SURGICAL REMOVAL OF THE TWMOR
Authors: KONG FM ANSCHER MS MURASE T ABBOTT BD IGLEHART JD JIRTLE RL
Citation: Fm. Kong et al., ELEVATED PLASMA TRANSFORMING GROWTH FACTOR-BETA(1) LEVELS IN BREAST-CANCER PATIENTS DECREASE AFTER SURGICAL REMOVAL OF THE TWMOR, Annals of surgery, 222(2), 1995, pp. 155-162
Risultati: 1-25 | 26-35